You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Summary of Product Characteristics

This link will take you to the electronic Medicines Compendium (eMC) website which is a non-GSK website.

Summary of product characteristics UK

Patient information leaflet

This link will take you to the electronic Medicines Compendium (eMC) website which is a non-GSK website.

Patient information leaflet UK

Patient information

Patient information

This information is specifically for patients who have been prescribed Trelegy Ellipta by a UK healthcare professional

I am a Trelegy COPD patient

Safety information

For safety information on Trelegy Ellipta including information on who is suitable for a Trelegy Ellipta prescription, please see the Trelegy Ellipta patient information leaflet linked above

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/.
By reporting side effects you can help provide more information on the safety of this medicine.

Trelegy and Ellipta are registered trademarks of the GlaxoSmithKline group of companies